跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XEOMIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
XEOMIN
Authorized
STANDARD
XEOMIN
MERZ PHARMACEUTICALS GMBH
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b6fb2d617155da04
Company
MERZ PHARMACEUTICALS GMBH
Type
Standard
Approval Details
Approval Id
b6fb2d617155da04
Drug Approval Canada Name
XEOMIN
Product Name
XEOMIN
Status
Approved
Status Date
2025-03-17
Din
02556227
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intraglandular , Intramuscular
Schedule
Prescription , Schedule D
Ahfs
12:20.20.24
Atc Original
M03AX01 BOTULINUM TOXIN
Atc Name
m 03 ax 01
Aig Number
0153613003
Company Name
MERZ PHARMACEUTICALS GMBH
Company Address
Eckenheimer Landstraße 100, Frankfurt, Hessen, Germany, 60318
Company Detail Path
/organization/merz-pharmaceuticals-gmbh
Company Information
Pharmaceutical Company Name
MERZ PHARMACEUTICALS GMBH
Country Name
United States
Province Name
Texas
City Name
frisco,texas,country_us
Address
8427 Plymouth Ln
Website
https://www.radiesse.de
Active Ingredients
INCOBOTULINUMTOXINA
200 UNIT / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b6fb2d617155da04
Type
Standard
Back to Health Canada Approvals